Claims for Patent: 5,767,251
✉ Email this page to a colleague
Summary for Patent: 5,767,251
| Title: | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
| Abstract: | Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH. |
| Inventor(s): | Reddy; Vermuri B. (Westboro, MA), Hsiung; Nancy (Wellesley, MA), Beck; Anton K. (Grisbeladierbeg, CH), Bernstine; Edward George (Boston, MA) |
| Assignee: | Genzyme Corporation (Cambridge, MA) |
| Application Number: | 08/008,233 |
| Patent Claims: | 1. A recombinantly produced biologically active heterodimeric human fertility hormone selected from the group consisting of human chorionic gonadotropin, human luteinizing hormone, and
human follicle stimulating hormone, free from contamination by any other proteins of human origin.
2. A recombinantly produced hormone in accordance with claim 1, wherein said hormone is human chorionic gonadotropin. 3. A recombinantly produced hormone in accordance with claim 1, wherein said hormone is human luteinizing hormone. 4. A recombinantly produced hormone in accordance with claim 1, wherein said hormone is human follicle stimulating hormone. |
Details for Patent 5,767,251
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | January 15, 1974 | ⤷ Subscribe | 2015-06-16 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | December 27, 1984 | ⤷ Subscribe | 2015-06-16 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 15, 1985 | ⤷ Subscribe | 2015-06-16 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 16, 1990 | ⤷ Subscribe | 2015-06-16 |
| Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | March 26, 1974 | ⤷ Subscribe | 2015-06-16 |
| Fresenius Kabi Usa, Llc | CHORIONIC GONADOTROPIN | chorionic gonadotropin | For Injection | 017067 | March 05, 1973 | ⤷ Subscribe | 2015-06-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,767,251
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 8604589 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 8501959 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 8501958 | ⤷ Subscribe |
| United States of America | 6455282 | ⤷ Subscribe |
| United States of America | 5856137 | ⤷ Subscribe |
| United States of America | 5639640 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
